Related Experiment Video
Updated: Oct 16, 2025

Measurements of Physiological Stress Responses in C. Elegans
Published on: May 21, 2020
Small molecule-mediated induction of endoplasmic reticulum stress in cancer cells
Shalini Pandey1,2, Virender Kumar Sharma3, Ankur Biswas1
1Department of Chemistry, Indian Institute of Science Education and Research (IISER)-Pune Homi Bhabha Road, Pashan Pune 411008 India ankur.biswas@students.iiserpune.ac.in.
Abstract:
The endoplasmic reticulum (ER) is one of the crucial sub-cellular organelles controlling myriads of functions including protein biosynthesis, folding, misfolding and unfolding. As a result, dysregulation of these pathways in the ER is implicated in cancer development and progression. Subsequently, targeting the ER in cancer cells emerged as an interesting unorthodox strategy in next-generation anticancer therapy. However, development of small molecules to selectively target the ER for cancer therapy remained elusive and unexplored. To address this, herein, we have developed a novel small molecule library of sulfonylhydrazide-hydrazones through a short and concise chemical synthetic strategy. We identified a fluorescent small molecule that localized into the endoplasmic reticulum (ER) of HeLa cells, induced ER stress followed by triggering autophagy which was subsequently inhibited by chloroquine (autophagy inhibitor) to initiate apoptosis. This small molecule showed remarkable cancer cell killing efficacy in different cancer cells as mono and combination therapy with chloroquine, thus opening a new direction to illuminate ER-biology towards the development of novel anticancer therapeutics.
Insights
Researchers developed a novel small molecule targeting the endoplasmic reticulum (ER) to induce cancer cell death. This molecule triggers ER stress and apoptosis, showing promise for new anticancer therapies.
Area of Science:
- Cell Biology
- Molecular Biology
- Drug Discovery
Background:
- The endoplasmic reticulum (ER) is vital for protein homeostasis and its dysfunction is linked to cancer.
- Targeting the ER presents a novel strategy for cancer therapy, but selective small molecules are lacking.
Purpose of the Study:
- To develop and evaluate novel small molecules for selective ER targeting in cancer therapy.
- To investigate the mechanism of action of a novel ER-targeting small molecule.
Main Methods:
- Synthesis of a sulfonylhydrazide-hydrazone small molecule library.
- Fluorescent imaging to confirm ER localization in HeLa cells.
- Assessment of ER stress, autophagy induction, and apoptosis in cancer cells.
Main Results:
- A novel fluorescent small molecule was identified that localizes to the ER.
- The molecule induced ER stress and triggered autophagy, which, when inhibited by chloroquine, led to apoptosis.
- Significant cancer cell killing efficacy was observed in mono and combination therapy.
Conclusions:
- The developed small molecule effectively targets the ER and induces cancer cell death.
- This study opens a new avenue for ER-targeted anticancer drug development.
Related Concept Videos
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Regulation of the Unfolded Protein Response
Export of Misfolded Proteins out of the ER
The Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...

